• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透明质酸填充剂年轻化治疗后的并发症管理——基于算法的方法

Complication Management following Rejuvenation Procedures with Hyaluronic Acid Fillers-an Algorithm-based Approach.

作者信息

Snozzi Philippe, van Loghem Jani A J

机构信息

Smoothline, Bahnhofstrasse Zürich, Switzerland.

Falck Clinic, Falckstraat, Amsterdam, Netherlands.

出版信息

Plast Reconstr Surg Glob Open. 2018 Dec 17;6(12):e2061. doi: 10.1097/GOX.0000000000002061. eCollection 2018 Dec.

DOI:10.1097/GOX.0000000000002061
PMID:30656127
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6326607/
Abstract

BACKGROUND

Hyaluronic acid is an ideal facial filler, however, although established as both safe and effective, complications do occur. Treatment recommendations that combine both expert opinions and clinical trial data are currently lacking, partly due to difficulties with diagnoses, nonspecific diagnostic investigations, and certain disorders presenting with similar symptoms, thereby confounding diagnosis and treatment.

METHODS

The purpose of this article was to provide the aesthetic clinician with practical recommendations regarding complication diagnosis arising as a consequence of hyaluronic acid filler rejuvenation treatment. It also provides recommendations for their management using step-wise treatment algorithms that are based on published expert opinions, as well as the author's clinical experience.

RESULTS

Algorithms are provided for the most common categories of complication associated with hyaluronic acid filler treatment, that is, skin discoloration, edema, nodules, infection, and vascular compromise.

CONCLUSIONS

These guidelines are not intended to be complete or exhaustive but may prove informative for aesthetic clinicians who are responsible for treating patients with hyaluronic acid fillers. It may help to guide them on recognizing potential complications and it provides clear guidance on optimum treatment pathways.

摘要

背景

透明质酸是一种理想的面部填充剂,然而,尽管已被证实安全有效,但并发症确实会发生。目前缺乏结合专家意见和临床试验数据的治疗建议,部分原因在于诊断困难、诊断检查缺乏特异性,以及某些疾病症状相似,从而混淆了诊断和治疗。

方法

本文旨在为美容临床医生提供有关透明质酸填充剂年轻化治疗后并发症诊断的实用建议。本文还基于已发表的专家意见以及作者的临床经验,通过逐步治疗算法为并发症的处理提供建议。

结果

针对与透明质酸填充剂治疗相关的最常见并发症类别,即皮肤变色、水肿、结节、感染和血管损伤,提供了算法。

结论

这些指南并非旨在涵盖所有情况或详尽无遗,但对于负责使用透明质酸填充剂治疗患者的美容临床医生可能具有参考价值。它可能有助于指导他们识别潜在并发症,并为最佳治疗途径提供明确指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/686a00055c89/gox-6-e2061-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/4b0219a0e1d4/gox-6-e2061-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/5e94a6bd667f/gox-6-e2061-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/a9bf21968739/gox-6-e2061-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/31231f079e84/gox-6-e2061-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/71293d7da164/gox-6-e2061-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/a64d36c72948/gox-6-e2061-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/2c4282ea6feb/gox-6-e2061-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/253ff5b69e80/gox-6-e2061-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/7b5c5cef060d/gox-6-e2061-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/686a00055c89/gox-6-e2061-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/4b0219a0e1d4/gox-6-e2061-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/5e94a6bd667f/gox-6-e2061-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/a9bf21968739/gox-6-e2061-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/31231f079e84/gox-6-e2061-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/71293d7da164/gox-6-e2061-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/a64d36c72948/gox-6-e2061-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/2c4282ea6feb/gox-6-e2061-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/253ff5b69e80/gox-6-e2061-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/7b5c5cef060d/gox-6-e2061-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/6326607/686a00055c89/gox-6-e2061-g010.jpg

相似文献

1
Complication Management following Rejuvenation Procedures with Hyaluronic Acid Fillers-an Algorithm-based Approach.透明质酸填充剂年轻化治疗后的并发症管理——基于算法的方法
Plast Reconstr Surg Glob Open. 2018 Dec 17;6(12):e2061. doi: 10.1097/GOX.0000000000002061. eCollection 2018 Dec.
2
Global Aesthetics Consensus: Avoidance and Management of Complications from Hyaluronic Acid Fillers-Evidence- and Opinion-Based Review and Consensus Recommendations.全球美学共识:透明质酸填充剂并发症的预防与处理——基于证据和观点的综述及共识建议
Plast Reconstr Surg. 2016 Jun;137(6):961e-971e. doi: 10.1097/PRS.0000000000002184.
3
Treatment of Soft Tissue Filler Complications: Expert Consensus Recommendations.软组织填充剂并发症的治疗:专家共识推荐
Aesthetic Plast Surg. 2018 Apr;42(2):498-510. doi: 10.1007/s00266-017-1063-0. Epub 2018 Jan 5.
4
Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations.面部年轻化进展:A型肉毒毒素、透明质酸真皮填充剂及联合治疗——共识推荐
Plast Reconstr Surg. 2008 May;121(5 Suppl):5S-30S. doi: 10.1097/PRS.0b013e31816de8d0.
5
The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical considerations.透明质酸填充剂(瑞蓝)在面部整形手术中的作用:综述与技术考量
Plast Reconstr Surg. 2007 Nov;120(6 Suppl):41S-54S. doi: 10.1097/01.prs.0000248794.63898.0f.
6
A Randomized Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments.一项评估皮肤年轻化疗法联合肉毒素和全脸填充治疗效果的随机研究。
J Drugs Dermatol. 2018 Jan 1;17(1):48-54.
7
A problem-oriented approach to nodular complications from hyaluronic acid and calcium hydroxylapatite fillers: classification and recommendations for treatment.一种针对透明质酸和羟磷灰石填充剂结节性并发症的以问题为导向的处理方法:分类和治疗建议。
Plast Reconstr Surg. 2013 Oct;132(4 Suppl 2):48S-58S. doi: 10.1097/PRS.0b013e31829e52a7.
8
Study and Analysis of the Clinical Effects and Maintenance Duration of Facial Rejuvenation Treatment in Middle-Aged and Elderly Individuals through the Combined Use of Facial Hyaluronic Acid Fillers and PPDO Thread Lift.透明质酸面部填充剂联合聚对二氧环己酮线雕对面部年轻化治疗的中年及老年个体临床效果及维持时间的研究与分析
Altern Ther Health Med. 2024 Jul 19.
9
Repeated Full-Face Aesthetic Combination Treatment With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin-Boosting Hyaluronic Acid After Monotherapy With AbobotulinumtoxinA or Hyaluronic Acid Filler.重复使用阿 Botox(保妥适)、透明质酸填充剂和皮肤增强型透明质酸进行全脸美学联合治疗,在单独使用阿 Botox(保妥适)或透明质酸填充剂治疗后。
Dermatol Surg. 2020 Apr;46(4):475-482. doi: 10.1097/DSS.0000000000002165.
10
MD Codes™: A Methodological Approach to Facial Aesthetic Treatment with Injectable Hyaluronic Acid Fillers.MD CodesTM:一种使用注射用透明质酸填充物进行面部美学治疗的方法学方法。
Aesthetic Plast Surg. 2021 Apr;45(2):690-709. doi: 10.1007/s00266-020-01762-7. Epub 2020 May 22.

引用本文的文献

1
Nonsurgical Rhinoplasty: A Modified Rino-4-Puntos Technique With Hyaluronic Acid Improves the Appearance of Nasal Septal Deviation.非手术隆鼻术:一种使用透明质酸的改良鼻四点技术改善鼻中隔偏曲外观。
Plast Reconstr Surg Glob Open. 2025 May 23;13(5):e6801. doi: 10.1097/GOX.0000000000006801. eCollection 2025 May.
2
Analysis of the clinical application and treatment effects of Ultra-Pulse Shockwave technology in facial rejuvenation.超脉冲冲击波技术在面部年轻化中的临床应用及治疗效果分析
Lasers Med Sci. 2025 Mar 8;40(1):131. doi: 10.1007/s10103-025-04395-x.
3
Prevention and Management of Complications With a Hyaluronic Acid-Calcium Hydroxyapatite Hybrid Injectable.

本文引用的文献

1
The American Society for Aesthetic Plastic Surgery's Cosmetic Surgery National Data Bank: Statistics 2018.美国美容整形外科学会的整形外科学全国数据库:2018年统计数据
Aesthet Surg J. 2019 Jun 21;39(Suppl_4):1-27. doi: 10.1093/asj/sjz164.
2
Intralesional Laser Treatment for Dermal Filler Complications.皮内激光治疗皮肤填充剂并发症。
Plast Reconstr Surg. 2018 Jun;141(6):1361-1369. doi: 10.1097/PRS.0000000000004428.
3
Restoration of Visual Loss With Retrobulbar Hyaluronidase Injection After Hyaluronic Acid Filler.透明质酸填充剂注射后球后注射透明质酸酶恢复视力丧失
透明质酸-羟基磷灰石混合可注射剂并发症的预防与管理
Clin Cosmet Investig Dermatol. 2025 Feb 21;18:431-441. doi: 10.2147/CCID.S506038. eCollection 2025.
4
Anatomical-Based Diagnosis and Filler Injection Techniques: Lips and Philtrum.基于解剖学的诊断与填充注射技术:唇部与鼻唇沟。
Life (Basel). 2025 Feb 18;15(2):315. doi: 10.3390/life15020315.
5
A Pilot One and Two-Year Prospective, Blinded Clinical Evaluation of Efficacy, and Safety of Combined Treatment With Crosslinked Hyaluronic Acid Dermal Filler and Barbed Polydioxanone Suspension Threads for Mid-Face Contour Enhancement.交联透明质酸真皮填充剂与倒刺聚二氧六环酮悬吊线联合治疗用于中面部轮廓改善的疗效和安全性的为期一年和两年的前瞻性、盲法临床试点评估。
J Cosmet Dermatol. 2025 Feb;24(2):e16700. doi: 10.1111/jocd.16700. Epub 2024 Dec 18.
6
Review of the Adverse Effects Associated with Dermal Filler Treatments: Part I Nodules, Granuloma, and Migration.与真皮填充剂治疗相关的不良反应综述:第一部分 结节、肉芽肿和移位
Diagnostics (Basel). 2024 Jul 30;14(15):1640. doi: 10.3390/diagnostics14151640.
7
Adverse Effects Associated with Dermal Filler Treatments: Part II Vascular Complication.与真皮填充剂治疗相关的不良反应:第二部分 血管并发症
Diagnostics (Basel). 2024 Jul 18;14(14):1555. doi: 10.3390/diagnostics14141555.
8
Nonsurgical Rhinoplasty: Results from a Retrospective Study of Rino-4-Puntos Technique with Hyaluronic Acid.非手术隆鼻术:透明质酸隆鼻四点技术的回顾性研究结果
Aesthetic Plast Surg. 2025 Feb;49(3):672-682. doi: 10.1007/s00266-024-04263-z. Epub 2024 Jul 25.
9
Late-Onset Reactions after Hyaluronic Acid Dermal Fillers: A Consensus Recommendation on Etiology, Prevention and Management.透明质酸真皮填充剂的迟发性反应:关于病因、预防和管理的共识建议
Dermatol Ther (Heidelb). 2024 Jul;14(7):1767-1785. doi: 10.1007/s13555-024-01202-3. Epub 2024 Jun 22.
10
Clinical Management With High-Frequency Ultrasound of Recurrent Submental Abscess Formation After Filler Placement: Bacterial Contamination or Immune-Mediated Adverse Event?填充剂注射后复发性颏下脓肿形成的高频超声临床管理:细菌污染还是免疫介导的不良事件?
Cureus. 2024 Apr 23;16(4):e58878. doi: 10.7759/cureus.58878. eCollection 2024 Apr.
Dermatol Surg. 2018 Mar;44(3):435-437. doi: 10.1097/DSS.0000000000001237.
4
Consensus statement on prevention and management of adverse effects following rejuvenation procedures with hyaluronic acid-based fillers.关于使用基于透明质酸的填充物进行年轻化治疗后预防和处理不良反应的共识声明。
J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1088-1095. doi: 10.1111/jdv.14295. Epub 2017 Jun 15.
5
The Management of Bruising following Nonsurgical Cosmetic Treatment.非手术美容治疗后瘀伤的管理
J Clin Aesthet Dermatol. 2017 Feb;10(2):E1-E4. Epub 2017 Feb 1.
6
New High Dose Pulsed Hyaluronidase Protocol for Hyaluronic Acid Filler Vascular Adverse Events.用于透明质酸填充剂血管不良事件的新型高剂量脉冲透明质酸酶方案
Aesthet Surg J. 2017 Jul 1;37(7):814-825. doi: 10.1093/asj/sjw251.
7
Efficacy of Retrobulbar Hyaluronidase Injection for Vision Loss Resulting from Hyaluronic Acid Filler Embolization.球后注射透明质酸酶治疗透明质酸填充剂栓塞所致视力丧失的疗效
Aesthet Surg J. 2017 Dec 13;38(1):12-22. doi: 10.1093/asj/sjw216.
8
The Role of Bacterial Biofilm in Adverse Soft-Tissue Filler Reactions: A Combined Laboratory and Clinical Study.细菌生物膜在软组织填充剂不良反应中的作用:一项实验室与临床联合研究
Plast Reconstr Surg. 2017 Mar;139(3):613-621. doi: 10.1097/PRS.0000000000003067.
9
Intravenous Hyaluronidase with Urokinase as Treatment for Rabbit Retinal Artery Hyaluronic Acid Embolism.静脉注射透明质酸酶联合尿激酶治疗兔视网膜动脉透明质酸栓塞
Plast Reconstr Surg. 2016 Dec;138(6):1221-1229. doi: 10.1097/PRS.0000000000002803.
10
Prevention and management of vision loss relating to facial filler injections.与面部填充剂注射相关的视力丧失的预防与管理。
Singapore Med J. 2016 Aug;57(8):438-43. doi: 10.11622/smedj.2016134.